A comparative study of magnetic sphincter augmentation and Nissen fundoplication in the management of GERD - Report - MDSpire

A comparative study of magnetic sphincter augmentation and Nissen fundoplication in the management of GERD

  • By

  • Zhihao Zhu

  • Jinlei Mao

  • Menghui Zhou

  • Minjun Xia

  • Junjie Wu

  • Qi Chen

  • Fei Zhao

  • Hongxia Liang

  • Zhifei Wang

  • October 14, 2024

  • 0 min

Share

Clinical Report: Magnetic Sphincter Augmentation vs Nissen Fundoplication for GERD

Overview

This retrospective study compared magnetic sphincter augmentation (MSA) and laparoscopic Nissen fundoplication (LNF) in treating gastroesophageal reflux disease (GERD). Both procedures demonstrated comparable safety and efficacy in symptom control and quality of life improvement, with MSA offering a novel, less invasive alternative.

Background

GERD is a common condition characterized by acid reflux and associated esophageal and extra-esophageal symptoms. While proton pump inhibitors are effective, long-term medication use may impact quality of life. Surgical options like LNF have been standard for anatomical correction, whereas MSA, approved in 2012, uses a magnetic device to augment the lower esophageal sphincter. Emerging evidence suggests MSA provides similar therapeutic benefits to LNF, prompting further comparative studies.

Data Highlights

ParameterMSA Group (n=16)LNF Group (n=24)
AgeMatchedMatched
GenderMatchedMatched
BMIMatchedMatched
Duration of GERD SymptomsMatchedMatched
GERD-Q ScoreMatchedMatched
Distal Contraction Integral (DCI)MatchedMatched
LES Resting PressureMatchedMatched

Key Findings

  • Both MSA and LNF groups were well matched demographically and clinically at baseline.
  • MSA utilizes a magnetic ring device to augment LES pressure, allowing physiological opening during swallowing.
  • LNF involves laparoscopic repair and fundoplication to prevent reflux by anatomical reconstruction.
  • Preoperative assessment included gastroscopy, high-resolution manometry, and contrast-enhanced ultrasonography.
  • MSA patients required 24-hour pH monitoring pre- and post-operatively, with follow-up chest X-ray and gastroscopy at one year.
  • Contraindications for MSA included large hiatal hernia (>2 cm), severe esophagitis (grade C/D), dysphagia, esophageal motility disorders, and future MRI needs.

Clinical Implications

MSA offers a less invasive surgical alternative to LNF with comparable safety and efficacy for selected GERD patients. Careful patient selection is essential, particularly excluding those with large hiatal hernias or severe esophagitis. Surgeons should be trained in the sizing and implantation technique of the magnetic device to optimize outcomes.

Conclusion

This study supports MSA as a viable surgical option for GERD management with similar effectiveness to LNF. Further prospective studies are warranted to confirm long-term outcomes and refine patient selection criteria.

References

  1. Global GERD prevalence 2017
  2. PPI efficacy and risks
  3. Laparoscopic Nissen fundoplication efficacy
  4. FDA approval of MSA (LINX system) 2012
  5. Initial MSA clinical data
  6. Comparative efficacy of MSA and LNF
  7. Safety profile of MSA
  8. SAGES guidelines on MSA
  9. Need for further comparative research

Original Source(s)

Related Content